KISUNLA

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

EL

Owner Name

Type: Organization / Corporation

Address

Lilly Corporate Center
Indianapolis, IN 46285

Critical Dates

First Use Date

Jul 31, 2024

Filing Date

Jun 8, 2021

Registration Date

Jun 24, 2025

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, central nervous system diseases and disorders, dementia, mental disorders, neurodegenerative diseases and disorders, and neurological disorders

Mark Elements

Text Mark
KISUNLA
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Jul 31, 2024

Filing Date

Jun 8, 2021

Publication Date

Feb 22, 2022

Registration Date

Jun 24, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI Assessment

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.